Guggenheim Capital LLC Sells 4,898 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)
Guggenheim Capital LLC decreased its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 12.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 35,988 shares of the biopharmaceutical company’s stock after selling 4,898 shares during the period. Guggenheim Capital LLC’s holdings in Cytokinetics were worth $1,693,000 as of its most recent […]
Guggenheim Capital LLC decreased its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 12.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 35,988 shares of the biopharmaceutical company’s stock after selling 4,898 shares during the period. Guggenheim Capital LLC’s holdings in Cytokinetics were worth $1,693,000 as of its most recent […]
